[The mechanism of membranotropic action of 1-ethoxysilatrane].
Rasulov
M M
MM
Kuznetsov
I G
IG
Belousov
A A
AA
Voronkov
M G
MG
D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects*; D008051:Lipid Bilayers / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects; D017646:Organosilicon Compounds; D051381:Rats; D012825:Silicon / Q000494:pharmacology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013050:Spectrometry, Fluorescence
D001643:Bridged Bicyclo Compounds; D019086:Bridged Bicyclo Compounds, Heterocyclic; D001952:Bridged-Ring Compounds; D008051:Lipid Bilayers; D017646:Organosilicon Compounds; C042292:1-ethoxysilatrane; D000254:Sodium-Potassium-Exchanging ATPase; D012825:Silicon
O mekhanizme membranotropnogo deĭstviia 1-étokxixilatrana.